This project is based on our discovery that genetic mutations in molecules that control the programmed death, or apoptosis, of lymphocytes is responsible for the Autoimmune Lymphoproliferative Syndrome (ALPS). ALPS is a disease affecting children that leads to loss of normal lymphocyte homeostasis leading to swollen lymph glands and organs. Because lymphocytes are the primary cell mediating immune reactions, this excess of lymphocytes leads to a pathological autoimmune attack on the patient?s own tissues. We have identified mutations in a death-inducing cell surface receptor termed Fas (also known as APO-1 or CD95) and, in the past year, proteolytic enzymes that are crucial to lymphocyte programmed cell death. We identified the structural alterations in the Fas receptor proteins encoded by the patients? mutations by nuclear magnetic resonance. These studies promise to provide new insights into the molecular mechanisms that underlie autoimmune disease as well as revealing crucial steps in the pathway of programmed cell death in lymphocytes. - ALPS, apoptosis, propriocidal regulation, Fas, TNF, caspase, autoimmunity, lymphocyte - Human Subjects

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000769-03
Application #
6288969
Study Section
Special Emphasis Panel (LI)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Cerutti, Elisa; Campagnoli, Maria F; Ferretti, Massimo et al. (2007) Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome. BMC Immunol 8:28
Lemmers, Benedicte; Salmena, Leonardo; Bidere, Nicolas et al. (2007) Essential role for caspase-8 in Toll-like receptors and NFkappaB signaling. J Biol Chem 282:7416-23
Bi, Lilia L; Pan, George; Atkinson, T Prescott et al. (2007) Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib. BMC Med Genet 8:41
Oliveira, Joao B; Bidere, Nicolas; Niemela, Julie E et al. (2007) NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc Natl Acad Sci U S A 104:8953-8
Bidere, Nicolas; Su, Helen C; Lenardo, Michael J (2006) Genetic disorders of programmed cell death in the immune system. Annu Rev Immunol 24:321-52
Zhu, Shigui; Hsu, Amy P; Vacek, Marla M et al. (2006) Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. Hum Genet 119:284-94
Su, Helen; Bidere, Nicolas; Zheng, Lixin et al. (2005) Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 307:1465-8
Roesler, Joachim; Izquierdo, Jose-Maria; Ryser, Martin et al. (2005) Haploinsufficiency, rather than the effect of an excessive production of soluble CD95 (CD95{Delta}TM), is the basis for ALPS Ia in a family with duplicated 3' splice site AG in CD95 intron 5 on one allele. Blood 106:1652-9
Su, Helen; Bidere, Nicolas; Lenardo, Michael (2004) Another fork in the road: Foxo3a regulates NF-kappaB activation. Immunity 21:133-4
Kanno, Tomohiko; Kanno, Yuka; Siegel, Richard M et al. (2004) Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Mol Cell 13:33-43

Showing the most recent 10 out of 37 publications